Trial intelligence / Profile preview

Toremifene vs Tamoxifen in Premenopausal Breast Cancer

NCT02132000Phase 3Unknown

Start
Apr 2014
Primary completion
May 2020
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of toremifene in breast cancer. Status: unknown.

02

Drugs

toremifene
03

Conditions

breast cancer

Beyond the preview

Go deeper on NCT02132000.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02132000.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call